Once-Monthly Injection for Weight Loss: Ozempic and Wegovy Could Soon Change the Game
Breaking News in Medical Technology
A slow-release form of semaglutide may allow users of Wegovy or Ozempic to switch from weekly injections to once-monthly shots, according to recent studies. This exciting advancement holds potential for better patient adherence.
Details of the New Formulation
- The drug is encased in a hydrogel that slowly releases semaglutide.
- Injected under the skin, this depot leads to a steady stream of the medication.
Dr. Claire Megret from ADOCIA has stated that tests in pigs are forthcoming, highlighting the vision for clinical trials.
Impact on Patients
- Semaglutide mimics the GLP-1 hormone to suppress appetite and regulate insulin.
- Patients currently face challenges in adhering to weekly injections, with only a fraction maintaining the regimen after a year.
Converting to a monthly injection could enhance the quality of life for individuals managing diabetes and obesity.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.